Tag Archives: economics

The American Health Care Machine and You: A Call to Conscience–Human Consequences of Turning A Blind Eye

“A nation’s greatness is measured by how it treats its weakest members.” ~ Mahatma Gandhi “Let your conscience be your guide” is a conviction we have not learned as a society when it comes to health care. As a country we … Continue reading

Posted in Affordable Care Act, health access, Health Care Reform, health insurance, medical bankruptcy, patient care, policy and politics, public dialogue | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

The American Health Care Machine and You: A Call to Conscience– $40 million executive bonus and what $40 million could cover

 Health care is a top issue in the presidential race, but unmentioned is the $40. 2 million Golden Parachute for Humana’s CEO if the proposed merger with Aetna is approved.  “Humana CEO Bruce Broussard is primed for a huge payday. … Continue reading

Posted in Affordable Care Act, aging, budget cuts, community action, consumer protection, Economy, Health Care Reform, health care stories, health insurance, hospitals, long-term care, Medicare, patient care, patients' voice, policy and politics, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

The American Health Care Machine and You: A Call to Conscience–2—Blockades vs. Building Blocks

Health Care Reform and Its Blockades We have been fighting over state vs. federal regulation of insurance since 1869 when the Supreme Court ruled that “issuing a policy of insurance is not a transaction of commerce.” When Teddy Roosevelt introduced … Continue reading

Posted in Affordable Care Act, Health Care Reform, health insurance, hospitals, Medicare, patient safety, policy and politics, quality of care | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

The American Health Care Machine and You: A Call To Conscience not Calculators

The American Health Care Machine and You:  A Call to Conscience not Calculators ©.    Our health care system fails us.  It fails us not only as patients it fails the many health professionals who are also victims of the rules, … Continue reading

Posted in Affordable Care Act, aging, community action, Health Care Reform, health insurance, long-term care, Medicare, patient care, public dialogue, quality of care | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

See How America’s Health Care Costs and Outcomes Compare to Others

I have been busy on a project and not blogging as frequently.  Given the discussions about health care in the election, however, I thought people would find this brief graphic video by the Kaiser Family Foundation of interest.  It shows … Continue reading

Posted in Affordable Care Act, Economy, Health Care Reform, health insurance, patient safety, policy and politics, politics, prescription drugs, public dialogue, quality of care, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Who Have We Become?

Speaker Paul Ryan’s new call to repeal the Affordable Care Act is either a bluff or completely blind and heartless. Imperfect as it is—and the legislation certainly has flaws—the Act assures people have access to health insurance even with a … Continue reading

Posted in Affordable Care Act, Health Care Reform, health insurance, medical bankruptcy, Medicare, patient safety, pharmaceutical companies, politics | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

A Place for Your Voice and A Chance to be Heard–From the Heart Again

In 1995, I interviewed the President of the Kaiser Family Foundation for an article in HMO Magazine, which was published by the Group Health Association of America.  The issues about about a public voice are depressingly the same! “Unless we … Continue reading

Posted in Affordable Care Act, community based care, consumer protection, Health Care Reform, health insurance, patients' voice, policy and politics, quality of care | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What You CAN Do About Prescription Drug Costs

What American’s Think About Prices and What You Can Do                      “Corporations now spend at least $2.6 billion a year lobbying Congress—more than the $2 billion taxpayers spend funding the House and the Senate.”  The Week, July 31, 2015 What … Continue reading

Posted in consumer protection, Economy, health insurance, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , | Leave a comment